You are here

weight loss

Structure Therapeutics surges on promising early stage obesity drug data

Reuters

Fri, 09/29/23 - 10:21 am

Structure Therapeutics

clinical trials

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Yahoo/Bloomberg

Sun, 09/24/23 - 08:56 pm

Why a hidden message in Ozempic’s logo represents a big shift in drug branding

Fast Company

Fri, 09/22/23 - 12:03 pm

Novo Nordisk Is Already Working on Ozempic 2.0

Motley Fool

Thu, 09/7/23 - 10:12 am

Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company

FT.com

Tue, 09/5/23 - 11:38 am

Are weight loss drugs a win for the global economy?

Pharma Voice

Thu, 08/31/23 - 10:14 am

Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says

Fierce Pharma

Mon, 08/28/23 - 08:00 pm

Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says

Forbes

Fri, 08/25/23 - 09:48 am

Lars Fruergaard Jorgensen

3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer

Motley Fool

Thu, 08/24/23 - 09:50 pm

cardiovascular disease

Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print

Forbes

Mon, 08/21/23 - 10:38 am

Demand for weight loss drugs soars to nearly half of Americans

Pharma Voice

Wed, 08/16/23 - 10:14 am

Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance

MedCity News

Mon, 08/7/23 - 11:12 pm

Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?

Motley Fool

Wed, 08/2/23 - 10:16 am

Eli Lilly's Mounjaro shortage worsens ahead of potential obesity FDA approval

Fierce Pharma

Wed, 07/26/23 - 11:26 am

New weight loss drugs carry high price tags and lots of questions for seniors

Medical Marketing and Media

Tue, 07/25/23 - 08:53 pm

Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher

Motley Fool

Thu, 07/6/23 - 11:17 am

More payers could stanch off-label use of Ozempic

Medical Marketing and Media

Mon, 06/19/23 - 10:24 am

Could Pfizer Have an Ozempic Killer on the Way?

Motley Fool

Mon, 06/5/23 - 10:07 am

Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence

Biopharma Reporter

Wed, 05/31/23 - 11:08 am

This Could Be Novo Nordisk's Next Big Weight-Loss Product

Motley Fool

Wed, 05/31/23 - 10:56 am

Pages